|
Volumn 33, Issue 2, 2008, Pages 224-
|
To the editor [1]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BONE MORPHOGENETIC PROTEIN 2;
BONE MORPHOGENETIC PROTEIN;
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2;
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2;
RECOMBINANT PROTEIN;
TRANSFORMING GROWTH FACTOR BETA;
UNCLASSIFIED DRUG;
ALLOGRAFT;
BONE GRAFT;
BONE RADIOGRAPHY;
BONE REMODELING;
CLINICAL PRACTICE;
CONTROL GROUP;
HUMAN;
LETTER;
OSTEOLYSIS;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
BONE DEVELOPMENT;
BONE REGENERATION;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
DRUG IMPLANT;
INSTRUMENTATION;
METHODOLOGY;
NOTE;
POSTOPERATIVE COMPLICATION;
RADIOGRAPHY;
SPINE FUSION;
TREATMENT OUTCOME;
BONE MORPHOGENETIC PROTEINS;
BONE REMODELING;
BONE RESORPTION;
DRUG IMPLANTS;
HUMANS;
OSSEOINTEGRATION;
OSTEOGENESIS;
POSTOPERATIVE COMPLICATIONS;
RECOMBINANT PROTEINS;
SPINAL FUSION;
TRANSFORMING GROWTH FACTOR BETA;
TREATMENT OUTCOME;
|
EID: 39049095876
PISSN: 03622436
EISSN: 15281159
Source Type: Journal
DOI: 10.1097/BRS.0b013e31816068e2 Document Type: Letter |
Times cited : (6)
|
References (2)
|